1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine

Term ID

CHEBI:86182

Synonyms

1-Docosahexaenoyl-2-palmitoyl-sn-glycero-3-phosphocholine
GPCho(22:6n3/16:0)
GPCho(22:6w3/16:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
PC(22:6n3/16:0)
PC(22:6w3/16:0)
Phosphatidylcholine(22:6n3/16:0)
Phosphatidylcholine(22:6w3/16:0)

Definition

A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl and hexadecanoyl respectively.

References

HMDB:HMDB0008725
LIPID_MAPS_instance:LMGP01011116

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidylcholine 38:6

phosphatidylcholine 38:6 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid hexadecanoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid hexadecanoic acid Show first 5 Terms

Phenotype

Phenotype resulting from 1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine

Human Disease Model